The Catalyst Group is made up of a diverse group of best-in-class industry professionals. Our team has a broad and varied background with global Pharmaceutical, Medical Device and Biotechnology companies and international regulatory authorities. We specialize in matching the best talent to your specific need—whenever and wherever you need it.
Bob Modan, CEO
Sajid ‘Bob’ Modan, RPh is a practicing clinical pharmacist and the CEO of The Catalyst Group. He started his career in pharmacovigilance at Pfizer and left the corporate world to launch SciStaff Services, a company initially dedicated to providing physician consultants in clinical development, medical affairs and drug safety. One of the company’s earliest successes was within the Ophthalmology therapeutic area when SciStaff had provided two physicians to Genentech that developed and launched Lucentis (ranimizumab injection), a $4B drug, for the treatment of wet form of age-related macular degeneration (AMD). Over the years, Sajid has shepherded the growth of the company by developing deep relationships with key executives and providing innovative solutions to the most challenging areas of the pharmaceutical industry. In 2011, with the critical help of his team, SciStaff spun off The Catalyst Group, a company dedicated to mitigating client risk in the areas of quality assurance, regulatory affairs and pharmacovigilance. Today The Catalyst Group works with global clients to provide consulting services that are critical in ensuring that drugs and devices that reach patients worldwide are safe and effective, a passion for everyone at the company.
Sajid graduated with a BS in Pharmacy from St. John’s University (Magna Cum Laude) and is currently a licensed pharmacist in New Jersey and Florida. In 2012, thanks to Pfizer’s support of minority owned businesses, he attended Dartmouth College, Tuck Business School’s intensive program on Executive Leadership.